Insulet Corporation

General ticker "PODD" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $15.6B (TTM average)

Insulet Corporation follows the US Stock Market performance with the rate: 67.2%.

Estimated limits based on current volatility of 3.6%: low 243.09$, high 261.36$

Factors to consider:

  • Company included in S&P500 list
  • US accounted for 74.7% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [195.59$, 314.24$]
  • 2025-12-31 to 2026-12-31 estimated range: [178.67$, 295.64$]

Financial Metrics affecting the PODD estimates:

  • Positive: Non-GAAP EPS, $ of 3.33 > 2.18
  • Negative: 0.10 < Interest expense per share, $ of 0.61
  • Negative: Industry operating cash flow per share per price (median), % of -3.89 <= 2.91
  • Negative: Industry earnings per price (median), % of -5.86 <= 0
  • Negative: Operating cash flow per share per price, % of 2.31 <= 7.10

Similar symbols

Short-term PODD quotes

2025-03-032025-03-042025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-11230240250260270280
Price $

Long-term PODD plot with estimates

150200250300350400450Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.51
PODDS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $1,305.30MM $1,697.10MM $2,071.60MM
Operating Expenses $1,267.70MM $1,477.10MM $1,762.70MM
Operating Income $37.60MM $220.00MM $308.90MM
Non-Operating Income $-27.80MM $-5.40MM $-8.70MM
Interest Expense $36.00MM $36.20MM $42.70MM
R&D Expense $180.20MM $205.00MM $219.60MM
Income(Loss) $9.80MM $214.60MM $300.20MM
Taxes $5.20MM $8.30MM $-118.10MM
Profit(Loss)* $4.60MM $206.30MM $418.30MM
Stockholders Equity $476.40MM $732.70MM $1,211.60MM
Inventory $346.80MM $402.60MM $430.40MM
Assets $2,251.10MM $2,588.20MM $3,087.70MM
Operating Cash Flow $119.00MM $145.70MM $430.30MM
Capital expenditure $157.30MM $75.60MM $124.90MM
Investing Cash Flow $-191.10MM $-119.40MM $-146.20MM
Financing Cash Flow $-40.30MM $-13.60MM $-28.10MM
Earnings Per Share** $0.07 $2.96 $5.97

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.